|
1
|
Aday AW and Beckman JA: Medical management
of asymptomatic carotid artery stenosis. Prog Cardiovasc Dis.
59:585–590. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wasserman BA, Haacke EM and Li D: Carotid
plaque formation and its evaluation with angiography, ultrasound,
and MR angiography. J Magn Reson Imaging. 4:515–527.
1994.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Coutts SB: Diagnosis and management of
transient ischemic attack. Continuum (Minneap Minn). 23:82–92.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Halliday A, Mansfield A, Marro J, Peto C,
Peto R, Potter J and Thomas D: MRC Asymptomatic Carotid Surgery
Trial (ACST) Collaborative Group. Prevention of disabling and fatal
strokes by successful carotid endarterectomy in patients without
recent neurological symptoms: Randomised controlled trial. Lancet.
363:1491–1502. 2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
O'Brien M and Chandra A: Carotid
revascularization: Risks and benefits. Vasc Health Risk Manag.
10:403–416. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
ACST-2 Collaborative Group. Halliday A,
Bulbulia R, Gray W, Naughten A, den Hartog A, Delmestri A, Wallis
C, le Conte S and Macdonald S: Status update and interim results
from the asymptomatic carotid surgery trial-2 (ACST-2). Eur J Vasc
Endovasc Surg. 46:510–518. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Abbott AL: Medical (nonsurgical)
intervention alone is now best for prevention of stroke associated
with asymptomatic severe carotid stenosis: Results of a systematic
review and analysis. Stroke. 40:e573–e583. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jiang W, Li T, Wang J, Jiao R, Shi X,
Huang X and Ji G: miR-140-3p suppresses cell growth and induces
apoptosis in colorectal cancer by targeting PD-L1. Onco Targets
Ther. 12:10275–10285. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ow SH, Chua PJ and Bay BH: miR-149 as a
potential molecular target for cancer. Curr Med Chem. 25:1046–1054.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gupta P, Bhattacharjee S, Sharma AR,
Sharma G, Lee SS and Chakraborty C: miRNAs in Alzheimer Disease-A
therapeutic perspective. Curr Alzheimer Res. 14:1198–1206.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Luan X, Zhou X, Naqvi A, Francis M, Foyle
D, Nares S and Diekwisch TGH: MicroRNAs and immunity in periodontal
health and disease. Int J Oral Sci. 10(24)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Navickas R, Gal D, Laucevicius A,
Taparauskaite A, Zdanyte M and Holvoet P: Identifying circulating
microRNAs as biomarkers of cardiovascular disease: A systematic
review. Cardiovasc Res. 111:322–337. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang T, Chen Z, Yang X, Fu R, Wang J and
Xu H: Circulating miR-106b-5p serves as a diagnostic biomarker for
asymptomatic carotid artery stenosis and predicts the occurrence of
cerebral ischemic events. Vasc Med. 25:436–442. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen G, Gao J, Sheng Y, Han X, Ji X, Zhao
M and Wu J: Diagnostic value of miR-92a in asymptomatic carotid
artery stenosis patients and its ability to predict cerebrovascular
events. Diagn Pathol. 15(74)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Qiao Y, Ma N, Wang X, Hui Y, Li F, Xiang
Y, Zhou J, Zou C, Jin J, Lv G, et al: MiR-483-5p controls
angiogenesis in vitro and targets serum response factor. FEBS Lett.
585:3095–3100. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jia L, Hao F, Wang W and Qu Y: Circulating
miR-145 is associated with plasma high-sensitivity C-reactive
protein in acute ischemic stroke patients. Cell Biochem Funct.
33:314–319. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Gallo W, Esguerra JLS, Eliasson L and
Melander O: miR-483-5p associates with obesity and insulin
resistance and independently associates with new onset diabetes
mellitus and cardiovascular disease. PLoS One.
13(e0206974)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Powers WJ, Derdeyn CP, Biller J, Coffey
CS, Hoh BL, Jauch EC, Johnston KC, Johnston SC, Khalessi AA,
Kidwell CS, et al: 2015 American Heart Association/American Stroke
Association Focused Update of the 2013 guidelines for the early
management of patients with acute ischemic stroke regarding
endovascular treatment: A guideline for healthcare professionals
from the American Heart Association/American stroke association.
Stroke. 46:3020–3035. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chi L, Jiao D, Nan G, Yuan H, Shen J and
Gao Y: miR-9-5p attenuates ischemic stroke through targeting
ERMP1-mediated endoplasmic reticulum stress. Acta Histochem.
121(151438)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhu L, Zhou X, Li S, Liu J, Yang J, Fan X
and Zhou S: miR1835p attenuates cerebral ischemia injury by
negatively regulating PTEN. Mol Med Rep. 22:3944–3954.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lv W, Zhang T, Zhao H, He S, Li B, Gao Y
and Pan W: Diagnostic value of miR-186-5p for carotid artery
stenosis and its predictive significance for future cerebral
ischemic event. Diagn Pathol. 15(101)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yan Z, Wang H, Liang J, Li Y and Li X:
MicroRNA-503-5p improves carotid artery stenosis by inhibiting the
proliferation of vascular smooth muscle cells. Exp Ther Med.
20(85)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Meschia JF, Klaas JP, Brown RD Jr and
Brott TG: Evaluation and management of atherosclerotic carotid
stenosis. Mayo Clin Proc. 92:1144–1157. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li S, Lee C, Song J, Lu C, Liu J, Cui Y,
Liang H, Cao C, Zhang F and Chen H: Circulating microRNAs as
potential biomarkers for coronary plaque rupture. Oncotarget.
8:48145–48156. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang ZG, Ma XD, He ZH and Guo YX:
miR-483-5p promotes prostate cancer cell proliferation and invasion
by targeting RBM5. Int Braz J Urol. 43:1060–1067. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tang S, Chen Y, Feng S, Yi T, Liu X, Li Q,
Liu Z, Zhu C, Hu J, Yu X, et al: MiR-483-5p promotes IGF-II
transcription and is associated with poor prognosis of
hepatocellular carcinoma. Oncotarget. 8:99871–99888.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shen Z, Tang W, Guo J and Sun S:
miR-483-5p plays a protective role in chronic obstructive pulmonary
disease. Int J Mol Med. 40:193–200. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
To KK, Tong CW, Wu M and Cho WC: MicroRNAs
in the prognosis and therapy of colorectal cancer: From bench to
bedside. World J Gastroenterol. 24:2949–2973. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Benz F, Roy S, Trautwein C, Roderburg C
and Luedde T: Circulating MicroRNAs as biomarkers for sepsis. Int J
Mol Sci. 17(78)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jia LH and Liu YN: Downregulated serum
miR-223 servers as biomarker in Alzheimer's disease. Cell Biochem
Funct. 34:233–237. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
32
|
Liu JD, Xin Q, Tao CS, Sun PF, Xu P, Wu B,
Qu L and Li SZ: Serum miR-300 as a diagnostic and prognostic
biomarker in osteosarcoma. Oncol Lett. 12:3912–3918.
2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kong Y, Ning L, Qiu F, Yu Q and Cao B:
Clinical significance of serum miR-25 as a diagnostic and
prognostic biomarker in human gastric cancer. Cancer Biomark.
24:477–483. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xu H, Yang Y, Zhao H, Yang X, Luo Y, Ren
Y, Liu W and Li N: Serum miR-483-5p: A novel diagnostic and
prognostic biomarker for patients with oral squamous cell
carcinoma. Tumour Biol. 37:447–453. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chabre O, Libe R, Assie G, Barreau O,
Bertherat J, Bertagna X, Feige JJ and Cherradi N: Serum miR-483-5p
and miR-195 are predictive of recurrence risk in adrenocortical
cancer patients. Endocr Relat Cancer. 20:579–594. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Qu X, Zhao M, Wu S, Yu W, Xu J, Xu J, Li J
and Chen L: Circulating microRNA 483-5p as a novel biomarker for
diagnosis survival prediction in multiple myeloma. Med Oncol.
31(219)2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wajima D, Nakagawa I, Takamura Y, Aketa S,
Yonezawa T and Nakase H: Carotid artery stenosis is exacerbated in
spontaneously obese model rats with diabetes. J Atheroscler Thromb.
21:1253–1259. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Vranic H, Hadzimehmedagic A,
Haxibeqiri-Karabdic I, Mujacic E and Djedovic M: Critical carotid
artery stenosis in coronary and non-coronary patients-frequency of
risk factors. Med Arch. 71:110–114. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Dong J, He M, Li J, Pessentheiner A, Wang
C, Zhang J, Sun Y, Wang WT, Zhang Y, Liu J, et al: microRNA-483
ameliorates hypercholesterolemia by inhibiting PCSK9 production.
JCI Insight. 5(e143812)2020.PubMed/NCBI View Article : Google Scholar
|
